Blog
C. R. Bard v. Angiodynamics – It’s a Labelled Injection Port, not a Label
Blog
Immunex v. Sanofi-Aventis – The “Mystery Dance” of Claim Construction
Blog
Biogen v. EMD Serono – “A Nest of Limitations”
Blog
The Patent Value Problem and the Case for Design-Around
Blog
USPTO Announces Program to Eliminate Filing Fees in Exchange for Early Publication of COVID-19 Applications
Blog
XY, LLC v. Trans Ova Genetics, Inc. – Building on Illumina v. Ariosa
Blog
Fed. Cir. Panel Holds that Judge Dyk Erred in Construction of Antibody Claims
Blog
AAM v. Neapco – Part IV – Petition for Rehearing En Banc Denied – “Bad Vibrations”
Blog
AAM v. Neapco – Part III – The Dissent Faces a “Perfect Storm” of Conflated Doctrines
Blog
AAM v. Neapco Part II– Judge Moore’s Dissent – Nothing More = Nevermore?
Blog
AAM v. Neapco: Method of Manufacturing Claim Gets the 101 Hook(e)
Blog